In a research report issued today, Roth Capital analyst Chris Lewis maintained a Buy rating on EnteroMedics Inc (NASDAQ:ETRM) with a $3 price target, as …
Before the market opened Tuesday, Roth Capital analyst Chris Lewis reiterated a Buy rating on Enteromedics (NASDAQ:ETRM) with a $3 price target, which represents …
In a research report issued a short while ago, Canaccord Genuity analyst William Plovanic maintained a Buy rating on Enteromedics (NASDAQ:ETRM) with a …
In a research report published today, Roth Capital analyst Chris Lewis maintained a Buy rating on Enteromedics (NASDAQ:ETRM) with a $3.00 price target, …
In a research report issued today, Roth Capital analyst Chris Lewis maintained a Buy rating on Enteromedics (NASDAQ:ETRM) with a $5 price target, following today’s …
In a research report published yesterday, Roth Capital analyst Chris Lewis maintained a Buy rating on EnteroMedics Inc. (ETRM) with a $5 price …
In a research note published yesterday, Roth Capital analyst Chris Lewis reaffirmed a Buy rating on EnteroMedics Inc. (ETRM) with a $5 price …
In a research note issued today, Roth Capital analyst Chris Lewis reiterated a Buy rating and boosted his price target on EnteroMedics Inc. (ETRM) to $5.
In a research note issued today, Roth Capital reiterated coverage with a “Buy” rating on EnteroMedics Inc. (ETRM), and a price target of $3.
